Your browser doesn't support javascript.
loading
PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor.
Degryse, B; Sier, C F; Resnati, M; Conese, M; Blasi, F.
Afiliação
  • Degryse B; Molecular Genetics Unit, DIBIT, Department of Cell Biology and Functional Genetics, University Vita-Salute San Raffaele, Via Olgettina 58, 20132 Milan, Italy.
FEBS Lett ; 505(2): 249-54, 2001 Sep 14.
Article em En | MEDLINE | ID: mdl-11566185
ABSTRACT
PAI-1 (plasminogen activator inhibitor-1) binds the urokinase-type plasminogen activator (uPA) and causes its degradation via its receptor uPAR and low-density lipoprotein receptor-related protein (LRP). While both uPA and PAI-1 are chemoattractants, we find that a preformed uPA-PAI-1 complex has no chemotactic activity and that PAI-1 inhibits uPA-induced chemotaxis. The inhibitory effect of PAI-1 on uPA-dependent chemotaxis is reversed when uPAR internalization is inhibited by the 39 kDa receptor-associated protein or by anti-LRP antibodies. Under the same conditions, the uPA-PAI-1 complex is turned into a chemoattractant causing cytoskeleton reorganization and extracellular-regulated kinase/mitogen-activated protein kinases activation. Thus, uPAR internalization by PAI-1 regulates cell migration.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ativador de Plasminogênio Tipo Uroquinase / Quimiotaxia / Inibidor 1 de Ativador de Plasminogênio / Receptores de Superfície Celular Idioma: En Ano de publicação: 2001 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ativador de Plasminogênio Tipo Uroquinase / Quimiotaxia / Inibidor 1 de Ativador de Plasminogênio / Receptores de Superfície Celular Idioma: En Ano de publicação: 2001 Tipo de documento: Article